Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of R21/Matrix-M malaria vaccine
PACTR202102694561794Phase 3Not yet recruiting
- Sponsor
- University of Oxford
- Start
- Feb 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 4
01
Overview
Phase 3, randomised trial of R21/Matrix-M in malaria (4 arms), sponsored by University of Oxford. Planned start Feb 2021; status: not yet recruiting.
02
Drugs
R21/Matrix-M
03
Conditions
malaria
Beyond the preview
Go deeper on PACTR202102694561794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202102694561794.